Clinical Trial Update: Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors [NA]

View source ↗

Summary

A terminated clinical trial investigated whether angiotensin-converting enzyme inhibitors reduce recurrence in chronic subdural hematoma; results posted in 2020…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• Angiotensin-converting enzyme inhibitors

Snippet

Sponsor: Odense University Hospital | Conditions: Hematoma, Subdural, Chronic | NA | Status: TERMINATED | Results posted: 2020-08-19